InvestorsHub Logo
icon url

peregr

05/23/20 5:20 AM

#333914 RE: Bluerinse #333909

Looking back, truly amazing that King could bring in $55M in revenue and the manufacturing side of the business was just his side gig. Now the fully dedicated team, and all the business development staff, is now down to $53m.

Interestingly, stumbled across a recent research article on failed PH3 trials. In discussing Peregrine, at the interim lookin the decision became quite simple. To continue and not overtake the placebo/control arm the company would have run out of money.

icon url

bigdumbandugly

05/24/20 11:08 AM

#333920 RE: Bluerinse #333909

No one's ever gone broke betting against an upcoming PPHM/CDMO CC.

In reality i do not see ANY scenario where they will have ANY chance of posting encouraging results from the past 1/4.

We don't even know when they went back on-line... assuming they did so. No excuse for that. Analysts probably won't even ask for dates - just more softballs and tangential nothingness.


Here's a snapshot of CDMO and a mud-caked sow. See if you can tell the difference:

https://thumbs.dreamstime.com/b/two-pigs-wallow-mud-bath-hot-day-cooling-themselves-off-as-field-summer-32605170.jpg

PS: yep, i agree, Tech0200. Been there done that. And as if you would need anything to jog your memory about this company's treatment of shareholders, just google the Deliverance mountain man scene with Ned Beatty.